CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8 + T cells in vitro

AIDS Research and Human Retroviruses

Volumn 23, Issue 3, 2007, Pages 438-450

  Kinter, Audrey L ^a,c   Horak, Robin ^a   Sion, Melanie ^a   Riggin, Lindsey ^a   McNally, Jonathan ^a   Lin, Yin ^a   Jackson, Robert ^a   O'Shea, Angeline ^a   Roby, Gregg ^a   Kovacs, Colin ^b   Connors, Mark ^a   Migueles, Stephen A ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c MSC 1576 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CD4 ANTIGEN; CD8 ANTIGEN; GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANTIVIRAL ACTIVITY; ARTICLE; CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DYSREGULATION; IMMUNOTHERAPY; IN VITRO STUDY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; VIRUS REPLICATION;

CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOCOMPROMISED HOST; INTERFERON TYPE II; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247241493     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0162     Document Type: Article

References (66)

1. Miedema F: Immunological abnormalities in the natural history of HIV infection: Mechanisms and clinical relevance. Immunodefic Rev 1992;3:173-193.
2. Moss RB, Richieri SP, Ferre, F, Daigle AE, Trauger R, Theofan G, et al.: HIV-1-specific functional immune measurements as markers of disease progression. J Biomed Sci 1997;4:127-131.
3. Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, et al.: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 1989;84:1892-1899.
4. Matano T, Shibata R, Siemon C, Connors M, Lane HC, and Martin MA: Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 1998;72:164-169.
5. + lymphocytes. Science 1999;283:857-860.
6. Gandhi RT and Walker BD: Immunologic control of HIV-1. Annu Rev Med 2002;53:149-172.
7. + T-cell response in HIV infection. AIDS Rev 2004;6:79-88.
8. Yang OO, and Walker BD: CD8+ cells in human immunodeficiency virus type I pathogenesis: Cytolytic and noncytolytic inhibition of viral replication. Adv Immunol 1997;66:273-311.
9. Migueles SA and Connors M: The Role of CD4(+) and CD8(+) T cells in controlling HIV infection. Curr Infect Dis Rep 2002;4:461-467.
10. Borrow P: Mechanisms of viral clearance and persistence. J Viral Hepat 1997;4(Suppl 2):16-24.
11. Pantaleo G and Koup RA: Correlates of immune protection in HIV-1 infection: What we know, What we don't know, what we should know. Nat Med 2004;10:806-810.
12. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-4655.
13. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, et al.: Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001;412:334-338.
14. Borrow P, Lewicki H, Hahn BH, Shaw GM, and Oldstone MB: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-6110.
15. Feeney ME, Tang Y, Roosevelt KA, Leslie AJ, McIntosh K, Karthas N, et al.: Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J Virol 2004;78: 8927-8930.
16. Lichterfeld M, Kaufmann DE, Yu XG, Mui SK, Addo MM, Johnston MN, et al.: Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med 2004; 200:701-712.
17. + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002;3:1061-1068.
18. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al.: HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006;107:4781-4589.
19. Zanussi S, Simonelli C, D'Andrea M, Caffau C, Clerici M, Tirelli U, et al.: CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection. Clin Exp Immunol 1996;105:220-224.
20. Suvas S, Azkur AK, Kim BS, Kumaraguru U, and Rouse BT: CD4(+)CD25(+) regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 2004;172:4123-4132.
21. Belkaid Y and Rouse BT: Natural regulatory T cells in infectious disease. Nat Immunol 2005;6:353-360.
22. Rouse BT and Suvas S: Regulatory cells and infectious agents: Detentes cordiale and contraire. J Immunol 2004;173:2211-2215.
23. Shevach EM: Regulatory/suppressor T cells in health and disease. Arthritis Rheum 2004;50:2721-2724.
24. Schwartz RH: T cell anergy. Annu Rev Immunol 2003;21:305-334.
25. Effros RB: Replicative senescence: The final stage of memory T cell differentiation? Curr HIV Res 2003;1:153-165.
26. Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, et al.: Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2004;2:E20.
27. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, and Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164.
28. + T cells restrict memory CD8+ T cell responses. J Exp Med 2002;196:1585-1592.
29. + T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 2003;198:889-901.
30. + T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. J Virol 2004;78:13082-13089.
31. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004;78:2454-2459.
32. Kinter AL, Hennessey M, Bell A, Kern S, Lin Y, Daucher M, et al.: CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004;200:331-343.
33. Oswald-Richter K, Grill SM, Shariat N, Leelawong M, Sundrud MS, Haas DW, et al.: HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2004;2:E198.
34. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004;104: 3249-3256.
35. Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, and Chang KM: Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 2003;38:1437-1448.
36. Franzese O, Kennedy PT, Gehring AJ, Gotto J, Williams R, Maini MK, et al.: Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005;79:3322-3328.
37. Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, Ferrari C, et al.: T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005;79:7860-7867.
38. Rushbrook SM, Ward SM, Unitt E, Vowler SL, Lucas M, Klenerman P, et al.: Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 2005;79:7852-7859.
39. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, et al.: Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005;41:771-778.
40. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, et al.: An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004;40:1062-1071.
41. Smyth MJ, Kelly JM, Sutton VR, Davis JE, Browne KA, Sayers TJ, et al.: Unlocking the secrets of cytotoxic granule proteins. J Leukoc Biol 2001;70:18-29.
42. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, et al.: Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997;3:205-211.
43. Dagarag M, Ng H, Lubong R, Effros RB, and Yang OO: Differential impairment of lytic and cytokine functions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J Virol 2003;77:3077-3083.
44. Lichterfeld M, Yu XG, Waring MT, Mui SK, Johnston MN, Cohen D, et al.: HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha. Blood 2004;104:487-494.
45. Betts MR, Brenchley JM, Price DA, De Rose SC, Douek DC, Roed-erer M, et al.: Sensitive and viable identification of antigen-specific CD8_ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281:65-78.
46. Mackewicz CE, Barker E, and Levy JA: Role of beta-chemokines in suppressing HIV replication. Science 1996;274:1393-1395.
47. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, and Lusso, P: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815.
48. Garzino-Demo A, Moss RB, Margolick JB, Cleghorn F, Sill A, Blattner WA, et al.: Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status. Proc Natl Acad Sci USA 1999;96:11986-11991.
49. Collins KL and Baltimore D: HIV's evasion of the cellular immune response. Immunol Rev 1999;168:65-74.
50. Chirmule N and Pahwa S: Envelope glycoproteins of human immunodeficiency virus type 1: Profound influences on immune functions. Microbiol Rev 1996;60:386-406.
51. Johnson WE and Desrosiers RC: Viral persistance: HIV's strategies of immune system evasion. Annu Rev Med 2002;53:499-518.
52. Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley IM, Casazza JP, et al.: Analysis of total human immunodeficiency virus (HrV)-specific CD4(+) and CD8(+) T-cell responses: Relationship to viral load in untreated HIV infection. J Virol 2001;75:11983-11991.
53. Lieberman J: Tracking the killers: How should we measure CD8 T cells in HIV infection? AIDS 2004;18:1489-1493.
54. Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, et al.: HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000;192:63-75.
55. Piccirllo CA and Shevach EM: Cutting edge: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001;167:1137-1140.
56. Estes JD, Li Q, Reynolds MR, Wietgrefe S, Duan L, Schacker T, et al.: Premature induction of an immunosuppressive regulatory T cell response during acute simian, immunodeficiency virus infection. J Infect Dis 2006;193:703-712.
57. Hel Z, Venzon D, Poudyal M, Tsai WP, Giuliani L, Woodward R, et al.: Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques. Nat Med 2000;6:1140-1146.
58. Wherry EJ, Blattman JN, and Ahmed R: Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination. J Virol 2005;79:8960-8968.
59. Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, Hoh R, et al.: Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 2005;79:14169-14178.
60. Betts MR, Exley B, Price DA, Bansal A, Camacho ZT, Teaberry V, et al.: Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc Natl Acad Sci USA 2005;102: 4512-4517.
61. Eggena MP, Barugahare B, Jones N, Okello M, Mutalya S, Kityo C, et al.: Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005;174:4407-4414.
62. Andersson J, Boasso A, Nilsson J, Zhang R, Shire NJ, Lindback S, et al.: Cutting edge: The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 2005;174:3143-3147.
63. Epple HJ, Loddenkemper C, Kunkel D, Troeger H, Maul J, Moos V, et al.: Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 2006;108:3072-3078.
64. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, and Sacks DL: CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002;420:502-507.
65. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al.: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-949.
66. Walker LS, Chodos A, Eggena M, Dooms H, and Abbas AK: Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 2003;198:249-258.